Related by context. Frequent words. (Click for all words.) 68 resectable 68 advanced adenomas 67 pancreatic adenocarcinoma 67 biochemical recurrence 66 renal tumors 66 metastatic RCC 65 castrate resistant prostate cancer 65 HNSCC 65 locoregional 65 lymph node involvement 65 PCa 65 neoadjuvant therapy 65 lymphadenectomy 65 metastatic renal cell carcinoma 65 T2DM 65 lymph node metastases 65 unresectable 64 metastatic lesions 64 HBeAg positive 64 colorectal carcinoma 64 resected 64 heavily pretreated 64 FOLFOX4 64 malignant pleural mesothelioma 64 non squamous NSCLC 64 hematologic toxicity 64 metastatic castration resistant 64 mCRC patients 64 distant metastasis 64 KRAS mutations 64 lymph node metastasis 64 neoadjuvant chemotherapy 64 cervical intraepithelial neoplasia 63 squamous 63 breast carcinoma 63 refractory chronic lymphocytic 63 recurrent glioblastoma 63 Erlotinib 63 Metastatic 63 Ischemic 63 multivariate analyzes 63 radical nephrectomy 63 thyroid nodules 63 cholangiocarcinoma 63 T#I [002] 63 secondary hyperparathyroidism 63 HER2 positive metastatic breast 63 gastrointestinal stromal tumors 63 HER2 negative 63 hepatocellular cancer 63 superficial bladder cancer 63 Irinotecan 63 adjuvant radiation 63 mRCC 63 HIV uninfected 63 pheochromocytoma 62 adenocarcinomas 62 non squamous 62 poor metabolizers 62 neovascular 62 radical cystectomy 62 metastatic liver 62 adjuvant chemotherapy 62 carboplatin paclitaxel 62 pericardial effusion 62 chemoradiotherapy 62 lung metastases 62 soft tissue sarcomas 62 grade gliomas 62 Epratuzumab 62 neoplasm 62 histologically 62 hyperparathyroidism 62 androgen independent 62 receiving VELCADE 62 Idiopathic Pulmonary Fibrosis 62 paclitaxel carboplatin 62 % CI #.#-#.# [003] 62 lymph node dissection 62 % CI #.#-#.# [007] 61 geographic atrophy 61 sustained virological response 61 KRAS wild 61 MGUS 61 distant metastases 61 myelodysplastic syndrome MDS 61 bendamustine 61 daunorubicin 61 EGFR mutations 61 multiple myeloma MM 61 relapsing multiple sclerosis 61 hepatocellular carcinoma HCC 61 PsA 61 Lenalidomide 61 carcinoid tumors 61 Chronic Hepatitis C 61 paclitaxel eluting stents 61 neoadjuvant 61 extracranial 61 pancreatic insufficiency 61 RRMS patients